Our findings provide the first mechanistic evidence linking loss-of-function Cav2.3 pathogenic variants to variable neurological phenotypes, expanding the clinical spectrum of <i>CACNA1E</i> channelopathies. This evidence concerns the gene CACNA1E and channelopathy.